Critical Contrast: Seagen (NASDAQ:SGEN) & Autolus Therapeutics (NASDAQ:AUTL)
EverQuote, Inc. (NASDAQ:EVER – Get Rating) CTO David Brainard sold 3,634 shares of the firm’s stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $6.90, for a total transaction of $25,074.60. Following the transaction, the chief technology officer now directly owns 158,450 shares in the […]